FindTrial
Sign In

Expression of a biomarker like Polyoma Enhancer Activator 3 may be higher in tooth-related neoplasms when compared to cysts.

Immunohistochemical Expression of Polyoma Enhancer Activator 3 in Odontogenic Cysts and Tumors: An Observational Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/066853
Enrollment
76
Registered
2024-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D103- Benign neoplasm of other and unspecified parts of mouth

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Institute of Dental Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Tissue blocks of odontogenic cysts that have been verified histopathologically 2 Tissue blocks of odontogenic tumors that have been verified histopathologically

Exclusion criteria

Exclusion criteria: Insufficient clinical data Tissues where controls exhibit unexpected results Tissues fixed in fixatives other than neutral buffered formalin

Design outcomes

Primary

MeasureTime frame
Immunohistochemical expression of polyoma enhancer activator 3 will be higher in odontogenic tumors as compared to cysts.Timepoint: NA—

Countries

India

Contacts

Public ContactDr Madhusudan Astekar

Institute of Dental Sciences

madhu.tanu@gmail.com7599247899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026